Merck & Co has made another move towards diversifying its pipeline and reducing its reliance on blockbuster cancer drug Keytruda, pledging $525 million to an alliance with Synthekine initially ...

I Tested Starlink’s Low-Cost $80-Per-Month Plan: It's Not the Downgrade I Expected By Brian Westover A Free One-Click Fix for Slow Computers? I Put Microsoft's PC Manager App to the Test By Michael ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

RMM Rivernorth Managed Duration Municipal Income Fund Inc.